Table 2.
Summary of ASA-response results compared across three testing platforms.
| Patient (n = 20) | LTA (MA %) | WB (ohms) | AspirinWorks (pg/mg) | ||||
|---|---|---|---|---|---|---|---|
| AA (500 μM) | Interp | Collagen (1 μg/ml) | Collagen (5 μg/ml) | Interp | AspirinWorks test | Interp | |
| A1 | 7 | Inhibited | 10 | 27 | Uninhibited | 1065 | Inhibited |
| A2 | 32 | Uninhibited | 5 | 11 | Inhibited | 1599 | Uninhibited |
| A3 | 22 | Inhibited | 6 | 16 | Inhibited | 1266 | Equivocal |
| A4 | 64 | Uninhibited | 18 | 19 | Uninhibited | 2833 | Uninhibited |
| A5 | 32 | Uninhibited | 6 | 12 | Inhibited | 1189 | Equivocal |
| A6 | 35 | Uninhibited | 8 | 17 | Inhibited | 711 | Inhibited |
| A7 | 29 | Uninhibited | 10 | 20 | Uninhibited | 1284 | Equivocal |
| A8 | 30 | Uninhibited | 13 | 22 | Uninhibited | 545 | Inhibited |
| A9 | 14 | Inhibited | 9 | 14 | Uninhibited | 640 | Inhibited |
| A10 | 24 | Inhibited | 6 | 11 | Uninhibited | 1030 | Equivocal |
| A11 | 67 | Uninhibited | 6 | 21 | Inhibited | 1467 | Uninhibited |
| A12 | 17 | Inhibited | 6 | 19 | Inhibited | 1327 | Equivocal |
| A13 | 14 | Inhibited | 6 | 14 | Inhibited | 1852 | Uninhibited |
| A14 | 19 | Inhibited | 7 | 13 | Uninhibited | 1187 | Equivocal |
| A15 | 28 | Uninhibited | 5 | 12 | Inhibited | 1838 | Uninhibited |
| A16 | 23 | Inhibited | 8 | 7 | Uninhibited | 654 | Inhibited |
| A17 | 22 | Inhibited | 6 | 14 | Inhibited | 3427 | Uninhibited |
| A18 | 15 | Inhibited | 18 | 22 | Uninhibited | 960 | Inhibited |
| A19 | 20 | Inhibited | 3 | 15 | Inhibited | 912 | Inhibited |
| A20 | 26 | Inhibited | 2 | 6 | Inhibited | 806 | Inhibited |
| # Positive agreement | # Negative agreement | Proportion of overall | |||||
| (Both tests Inhibited) | (Both tests Uninhibited or Equivocal) | agreement (PO) | |||||
| LTA vs. WBA | 6 | 3 | 45% | ||||
| LTA vs. AspirinWorks | 6 | 6 | 60% | ||||
| WBA vs. AspirinWorks | 3 | 4 | 35% | ||||
AA, arachidonic acid; LTA, Light transmission aggregometry; WBA, Whole blood aggregometry.